{
  "version": 1,
  "updatedAt": "2025-01-15T00:00:00Z",
  "scoringRules": {
    "age": {
      "<1 year": 8,
      "1-17 years": 2,
      "18-64 years": 0,
      "65-79 years": 5,
      "≥80 years": 10
    },
    "hospitalAdmission": {
      "None": 0,
      "1-2 days": 5,
      "3-7 days": 10,
      "8-14 days": 15,
      ">14 days": 20
    },
    "icuStay": {
      "No": 0,
      "Yes (<7 days)": 10,
      "Yes (≥7 days)": 15
    },
    "nursingHome": {
      "No": 0,
      "Yes (<30 days)": 8,
      "Yes (≥30 days)": 12
    },
    "hemodialysis": 10,
    "surgery": 5,
    "antibioticUse": {
      "None": 0,
      "1-3 days": 5,
      "4-7 days": 10,
      "8-14 days": 15,
      ">14 days": 20
    },
    "broadSpectrumAntibiotics": {
      "3rd/4th gen cephalosporins": 5,
      "Carbapenems": 8,
      "Fluoroquinolones": 5,
      "Piperacillin-tazobactam": 5
    },
    "invasiveDevices": {
      "Central line": 5,
      "Urinary catheter": 3,
      "Endotracheal tube": 8,
      "Surgical drain": 3
    },
    "immunosuppression": {
      "Chemotherapy": 10,
      "Solid organ transplant": 12,
      "Hematopoietic stem cell transplant": 15,
      "Chronic steroids (>10mg/day prednisone)": 5,
      "HIV/AIDS (CD4 <200)": 10
    },
    "chronicConditions": {
      "Diabetes mellitus": 3,
      "Chronic kidney disease": 5,
      "Chronic liver disease": 5,
      "COPD": 3,
      "Malignancy": 5
    },
    "priorMdro": {
      "No": 0,
      "Yes (>12 months ago)": 15,
      "Yes (within 12 months)": 25
    },
    "internationalTravel": 10,
    "knownMdroContact": 8
  },
  "riskThresholds": {
    "low": {
      "min": 0,
      "max": 20,
      "probability": 10,
      "label": "Low Risk"
    },
    "moderate": {
      "min": 21,
      "max": 40,
      "probability": 20,
      "label": "Moderate Risk"
    },
    "high": {
      "min": 41,
      "max": 60,
      "probability": 40,
      "label": "High Risk"
    },
    "veryHigh": {
      "min": 61,
      "max": 100,
      "probability": 60,
      "label": "Very High Risk"
    }
  },
  "organismRiskFactors": {
    "MRSA": {
      "highRiskFactors": ["nursingHome", "hemodialysis", "priorMRSA"],
      "moderateRiskFactors": ["hospitalAdmission", "surgery", "invasiveDevices"]
    },
    "VRE": {
      "highRiskFactors": ["icuStay", "broadSpectrumAntibiotics", "priorVRE"],
      "moderateRiskFactors": ["hospitalAdmission", "immunosuppression"]
    },
    "ESBL": {
      "highRiskFactors": ["broadSpectrumAntibiotics", "internationalTravel", "priorESBL"],
      "moderateRiskFactors": ["hospitalAdmission", "nursingHome", "urinaryCatheter"]
    },
    "CRE": {
      "highRiskFactors": ["carbapenems", "icuStay", "internationalTravel", "priorCRE"],
      "moderateRiskFactors": ["hospitalAdmission", "invasiveDevices"]
    },
    "MDR Pseudomonas": {
      "highRiskFactors": ["icuStay", "endotrachealTube", "broadSpectrumAntibiotics"],
      "moderateRiskFactors": ["hospitalAdmission", "invasiveDevices", "immunosuppression"]
    },
    "C. difficile": {
      "highRiskFactors": ["broadSpectrumAntibiotics", "age≥65", "hospitalAdmission"],
      "moderateRiskFactors": ["chronicConditions", "immunosuppression"]
    }
  },
  "recommendations": {
    "low": {
      "isolation": "Standard precautions",
      "screening": "No routine screening indicated",
      "empiricTherapy": "Standard community-acquired pathogen coverage (e.g., ceftriaxone, ampicillin-sulbactam)",
      "stewardship": [
        "Narrow-spectrum antibiotics preferred",
        "Standard antimicrobial stewardship protocols",
        "Document allergy history",
        "Review antibiotic necessity daily"
      ]
    },
    "moderate": {
      "isolation": "Consider contact precautions pending screening results",
      "screening": "Targeted screening for specific MDROs based on risk factors (MRSA nasal swab if LTCF/hemodialysis, VRE rectal swab if ICU/antibiotics)",
      "empiricTherapy": "Consider MRSA/ESBL coverage if septic (e.g., piperacillin-tazobactam + vancomycin)",
      "stewardship": [
        "De-escalate antibiotics based on culture results within 48-72 hours",
        "Consider infectious disease consultation for complex cases",
        "Document rationale for broad-spectrum therapy",
        "Review antibiotic necessity daily"
      ]
    },
    "high": {
      "isolation": "Contact precautions recommended",
      "screening": "Active surveillance cultures (nasal swab for MRSA, rectal swab for VRE/ESBL/CRE, wound cultures if applicable)",
      "empiricTherapy": "Broad-spectrum with MDRO coverage (e.g., meropenem + vancomycin)",
      "stewardship": [
        "Mandatory infectious disease consultation",
        "De-escalate antibiotics based on culture results within 48 hours",
        "Daily antimicrobial stewardship review",
        "Consider rapid diagnostic testing (PCR, MALDI-TOF)",
        "Document infection vs. colonization"
      ]
    },
    "veryHigh": {
      "isolation": "Strict contact precautions + cohorting; single room isolation preferred",
      "screening": "Comprehensive screening (nasal, rectal, throat, wounds, urine cultures)",
      "empiricTherapy": "Maximum broad-spectrum coverage; consider CRE coverage (e.g., meropenem + vancomycin + colistin or ceftazidime-avibactam)",
      "stewardship": [
        "Mandatory infectious disease consultation within 24 hours",
        "Daily antimicrobial stewardship review with ID team",
        "Rapid diagnostic testing (PCR, MALDI-TOF, molecular resistance testing)",
        "Consider novel agents (ceftazidime-avibactam, meropenem-vaborbactam, cefiderocol)",
        "Document infection vs. colonization",
        "Infection prevention consultation for cohorting/isolation strategies"
      ]
    }
  },
  "references": [
    {
      "title": "CDC - Management of Multidrug-Resistant Organisms (MDROs)",
      "url": "https://www.cdc.gov/infectioncontrol/guidelines/mdro/"
    },
    {
      "title": "WHO - Guidelines on Core Components of Infection Prevention and Control",
      "url": "https://www.who.int/publications/i/item/9789241549929"
    },
    {
      "title": "IDSA - Guidance on MDRO Surveillance and Prevention",
      "url": "https://www.idsociety.org/"
    },
    {
      "title": "SHEA/IDSA - Strategies to Prevent MDRO Transmission in Acute Care Hospitals",
      "url": "https://www.cambridge.org/core/journals/infection-control-and-hospital-epidemiology"
    },
    {
      "title": "APIC - MDRO Prevention Guide",
      "url": "https://apic.org/"
    },
    {
      "title": "European CDC - MDRO Surveillance Protocol",
      "url": "https://www.ecdc.europa.eu/"
    }
  ]
}

